scholarly journals Characterization of the cold-sensitive murine hepatitis virus mutants rescued from latently infected cells by cell fusion

Virology ◽  
1979 ◽  
Vol 98 (2) ◽  
pp. 448-455 ◽  
Author(s):  
Stephen A. Stohlman ◽  
Alan Y. Sakaguchi ◽  
Leslie P. Weiner
Keyword(s):  
Cell Fusion ◽  
Hepatitis Virus ◽  
Murine Hepatitis Virus ◽  
Latently Infected ◽  
Cold Sensitive ◽  
Infected Cells

scholarly journals Characterization of murine hepatitis virus (JHM) RNA from rats with experimental encephalomyelitis

Virology ◽  
1984 ◽  
Vol 137 (2) ◽  
pp. 297-304 ◽  
Author(s):  
Dennis P. Jackson ◽  
Dean H. Percy ◽  
Vincent L. Morris
Keyword(s):  
Hepatitis Virus ◽  
Murine Hepatitis Virus

scholarly journals Inhibiting ACSL1 related ferroptosis restrains MHV-A59 infection

2021 ◽  
Author(s):  
Huawei Xia ◽  
Zeming Zhang ◽  
Fuping You
Keyword(s):  
Hepatitis Virus ◽  
Murine Hepatitis Virus ◽  
Viral Propagation ◽  
Triacsin C ◽  
Representative Model ◽  
Infected Cells ◽  
Coronavirus Infection ◽  
Syncytia Formation ◽  
In Vivo Administration

Murine hepatitis virus strain A59 (MHV-A59) belongs to the β-coronavirus and is considered as a representative model for studying coronavirus infection. MHV-A59 was shown to induce pyroptosis, apoptosis and necroptosis of infected cells, especially the murine macrophages. However, whether ferroptosis, a recently identified form of lytic cell death, was involved in the pathogenicity of MHV-A59, is unknown. Here, we demonstrate inhibiting ferroptosis suppresses MHV-A59 infection. MHV-A59 infection upregulates the expression of Acsl1, a novel ferroptosis inducer. MHV-A59 upregulates Acsl1 expression depending on the NF-kB activation, which is TLR4-independent. Ferroptosis inhibitor inhibits viral propagation, inflammatory cytokines release and MHV-A59 infection induced cell syncytia formation. ACSL1 inhibitor Triacsin C suppresses MHV-A59 infection induced syncytia formation and viral propagation. In vivo administration of liproxstatin-1 ameliorates lung inflammation and tissue injuries caused by MHV-A59 infection. Collectively, these results indicate that ferroptosis inhibition protects hosts from MHV-A59 infection. Targeting ferroptosis may serves as a potential treatment approach for dealing with hyper-inflammation induced by coronavirus infection.

scholarly journals Identification and Characterization of Severe Acute Respiratory Syndrome Coronavirus Replicase Proteins

2004 ◽  
Vol 78 (18) ◽  
pp. 9977-9986 ◽  
Author(s):  
Erik Prentice ◽  
Josephine McAuliffe ◽  
Xiaotao Lu ◽  
Kanta Subbarao ◽  
Mark R. Denison
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Hepatitis Virus ◽  
Immunoblot Analysis ◽  
Vero Cells ◽  
Genome Replication ◽  
Protein Marker ◽  
Replicase Protein ◽  
Replicase Proteins ◽  
Infected Cells

ABSTRACT The severe acute respiratory syndrome coronavirus (SARS-CoV) encodes proteins required for RNA transcription and genome replication as large polyproteins that are proteolytically processed by virus-encoded proteinases to produce mature replicase proteins. In this report, we generated antibodies against SARS-CoV predicted replicase protein and used the antibodies to identify and characterize 12 of the 16 predicted mature replicase proteins (nsp1, nsp2, nsp3, nsp4, nsp5, nsp8, nsp9, nsp12, nsp13, nsp14, nsp15, and nsp16) in SARS-CoV-infected Vero cells. Immunoblot analysis of infected-cell lysates identified proteins of the predicted sizes. Immunofluorescence microscopy detected similar patterns of punctate perinuclear and distributed cytoplasmic foci with all replicase antibodies and as early as 6 h postinfection. Dual-labeling studies demonstrated colocalization of replicase protein nsp8 with nsp2 and nsp3 in cytoplasmic complexes and also with LC3, a protein marker for autophagic vacuoles. Antibodies directed against mouse hepatitis virus (MHV) virions and against the putative RNA-dependent RNA polymerase (Pol) detected SARS-CoV nucleocapsid and nsp12 (Pol), respectively, in SARS-CoV-infected Vero cells. These results confirm the predicted protein processing pattern for mature SARS-CoV replicase proteins, demonstrate localization of replicase proteins to cytoplasmic complexes containing markers for autophagosome membranes, and suggest conservation of protein epitopes in the replicase and nucleocapsid of SARS-CoV and the group II coronavirus, MHV. Further, the results demonstrate the ability of replicase antibodies to detect SARS-CoV-infected cells as early as 6 h postinfection and thus represent important tools for studies of SARS-CoV replication, inhibition, and diagnosis.

scholarly journals The coronavirus proofreading exoribonuclease mediates extensive viral recombination

2020 ◽  
Author(s):  
Jennifer Gribble ◽  
Andrea J. Pruijssers ◽  
Maria L. Agostini ◽  
Jordan Anderson-Daniels ◽  
James D. Chappell ◽  
...  
Keyword(s):  
Hepatitis Virus ◽  
Nonstructural Protein ◽  
Severe Disease ◽  
Rna Recombination ◽  
Murine Hepatitis Virus ◽  
Viral Recombination ◽  
Viral Genomes ◽  
Genetic Inactivation ◽  
Virus Inhibition ◽  
Infected Cells

SUMMARYCoronaviruses (CoVs) emerge as zoonoses and cause severe disease in humans, demonstrated by the SARS-CoV-2 (COVID-19) pandemic. RNA recombination is required during normal CoV replication for subgenomic mRNA (sgmRNA) synthesis and generates defective viral genomes (DVGs) of unknown function. However, the determinants and patterns of CoV recombination are unknown. Here, we show that divergent β-CoVs SARS-CoV-2, MERS-CoV, and murine hepatitis virus (MHV) perform extensive RNA recombination in culture, generating similar patterns of recombination junctions and diverse populations of DVGs and sgmRNAs. We demonstrate that the CoV proofreading nonstructural protein (nsp14) 3’-to-5’ exoribonuclease (nsp14-ExoN) is required for normal CoV recombination and that its genetic inactivation causes significantly decreased frequency and altered patterns of recombination in both infected cells and released virions. Thus, nsp14-ExoN is a key determinant of both high fidelity CoV replication and recombination, and thereby represents a highly-conserved and vulnerable target for virus inhibition and attenuation.

scholarly journals Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection

2021 ◽  
Vol 17 (6) ◽  
pp. e1009644
Author(s):  
Liliana Echavarría-Consuegra ◽  
Georgia M. Cook ◽  
Idoia Busnadiego ◽  
Charlotte Lefèvre ◽  
Sarah Keep ◽  
...  
Keyword(s):  
Unfolded Protein Response ◽  
Hepatitis Virus ◽  
Ribosome Profiling ◽  
Murine Hepatitis Virus ◽  
Unfolded Protein ◽  
Virion Release ◽  
Infected Cells ◽  
Coronavirus Infection ◽  
The Unfolded Protein Response ◽  
Protein Response

Coronavirus infection induces the unfolded protein response (UPR), a cellular signalling pathway composed of three branches, triggered by unfolded proteins in the endoplasmic reticulum (ER) due to high ER load. We have used RNA sequencing and ribosome profiling to investigate holistically the transcriptional and translational response to cellular infection by murine hepatitis virus (MHV), often used as a model for the Betacoronavirus genus to which the recently emerged SARS-CoV-2 also belongs. We found the UPR to be amongst the most significantly up-regulated pathways in response to MHV infection. To confirm and extend these observations, we show experimentally the induction of all three branches of the UPR in both MHV- and SARS-CoV-2-infected cells. Over-expression of the SARS-CoV-2 ORF8 or S proteins alone is itself sufficient to induce the UPR. Remarkably, pharmacological inhibition of the UPR greatly reduced the replication of both MHV and SARS-CoV-2, revealing the importance of this pathway for successful coronavirus replication. This was particularly striking when both IRE1α and ATF6 branches of the UPR were inhibited, reducing SARS-CoV-2 virion release (~1,000-fold). Together, these data highlight the UPR as a promising antiviral target to combat coronavirus infection.

scholarly journals Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection

Viruses ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 2383
Author(s):  
Huawei Xia ◽  
Zeming Zhang ◽  
Fuping You
Keyword(s):  
Hepatitis Virus ◽  
Infection Model ◽  
Murine Hepatitis Virus ◽  
Viral Propagation ◽  
Murine Macrophages ◽  
Triacsin C ◽  
Infected Cells ◽  
Coronavirus Infection ◽  
Syncytia Formation

Murine hepatitis virus strain A59 (MHV-A59) was shown to induce pyroptosis, apoptosis, and necroptosis of infected cells, especially in the murine macrophages. However, whether ferroptosis, a recently identified form of lytic cell death, was involved in the pathogenicity of MHV-A59 is unknown. We utilized murine macrophages and a C57BL/6 mice intranasal infection model to address this. In primary macrophages, the ferroptosis inhibitor inhibited viral propagation, inflammatory cytokines released, and cell syncytia formed after MHV-A59 infection. In the mouse model, we found that in vivo administration of liproxstatin-1 ameliorated lung inflammation and tissue injuries caused by MHV-A59 infection. To find how MHV-A59 infection influenced the expression of ferroptosis-related genes, we performed RNA-seq in primary macrophages and found that MHV-A59 infection upregulates the expression of the acyl-CoA synthetase long-chain family member 1 (ACSL1), a novel ferroptosis inducer. Using ferroptosis inhibitors and a TLR4 inhibitor, we showed that MHV-A59 resulted in the NF-kB-dependent, TLR4-independent ACSL1 upregulation. Accordingly, ACSL1 inhibitor Triacsin C suppressed MHV-A59-infection-induced syncytia formation and viral propagation in primary macrophages. Collectively, our study indicates that ferroptosis inhibition protects hosts from MHV-A59 infection. Targeting ferroptosis may serve as a potential treatment approach for dealing with hyper-inflammation induced by coronavirus infection.

Sign in / Sign up

Export Citation Format

Share Document